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IVUS phenotype changed from BL to FU in approximately half
of Event-NCLs and Non-event-NCLs, although the overall preva-
lence of each phenotype did not change (Table). New TCFAs from
non-TCFA phenotype developed in 25/110 NCLs (22.7%), including
4/11 Event-NCLs and 21/99 Non-event-NCLs (36.4% vs. 21.2%,
p¼0.26).Event-NCLs Follow-upBaseline TCFA ThCFA PIT Fibrotic Fibro-calciﬁcTCFA 6 (35.3%) 2 4 0 0 0ThCFA 9 (52.9%) 4 5 0 0 0PIT 1 (5.9%) 0 0 1 0 0Fibrotic 0 (0%) 0 0 0 0 0Fibrocalciﬁc 1 (5.9%) 0 1 0 0 0Total 17 6 (35.3%) 10 (58.8%) 1 (5.9%) 0 (0%) 0 (0%)Non-event-NCLsTCFA 28 (22.0%) 12 14 2 0 0ThCFA 46 (36.2%) 9 29 8 0 0PIT 50 (39.4%) 10 13 27 0 0Fibrotic 1 (0.8%) 1 0 0 0 0Fibrocalciﬁc 2 (1.6%) 1 1 0 0 0Total 127 33 (26.0%) 57 (44.9%) 37 (29.1%) 0 (0%) 0 (0%)CONCLUSIONS In the PROSPECT study, new TCFAs developed in
w23% of untreated NCLs during median 3.4 year FU. NCLs causing
events during FU tended to have greater progression of necrotic core
and dense calcium compared to NCLs which did not cause events. A
greater increase in plaque volume was also noted in Event-NCLs
compared to Non-event-NCLs, although the difference did not reach
statistical signiﬁcance.
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BACKGROUND Coronary calciﬁcation is a common ﬁnding in non-
invasive and invasive imaging studies. Coronary computed tomogra-
phy (CT) coronary artery calcium (CAC) testing is the most widely
used and validated score for studying coronary calciﬁcation. It is
considered to be a strong independent predictor of future adverse
cardiovascular events and also gives additional information than the
traditional cardiovascular risk factors. We investigated the natural
history of the coronary calciﬁcation as assessed by OCT in a popula-
tion with serial imaging over a period of 5 years.
METHODS We screened all patients from ABSORB cohort B trial and
we selected only the patients with available OCT data within 6 months
(baseline) after scaffold implantation and at follow-up (5 years). In the
ABSORB B trial (n¼101) patients with a diagnosis of stable or unstable
angina or silent ischemia were enrolled and treated with implantation
of ABSORB (3.0 x 18 mm). OCT datasets (baseline and 5 year follow-
up) were screened for the presence of calcium spots fully visible in
their entire extent without the presence of any artifact that may
prevent proper contouring of the calcium area.
RESULTS A total of 17 patients had 31 matched lesions with calciﬁed
spots at baseline and 5 year follow-up (21 were located outside of the
scaffolded segments and 10 in the scaffolded segments). At baseline,
the median calcium area (IQR) was 0.44 (0.28-0.72) vs. 0.75 (0.61-
0.90) mm2 at 5 years; the mean difference was 0.380.50 mm2,
p<0.001 (representing an 11096.3% increase). The rate of progres-
sion seems to be slower in those calcium spots within the scaffolded
segments compared to those located outside the scaffolded segments.
The mean minimum, maximum and mean distances from the lumen
remain unchanged over time. On average, the circumferential arc of
the calcium reduced slightly (although statistically signiﬁcant) from49.18 to 45.98 degrees while the length of the calcium increased not
signiﬁcantly (table 1).
CONCLUSIONS Near-microscopic resolution intravascular imaging
modality, such as OCT, allows a very detailed and highly reproducible
analysis of the calcium spots. This provides a unique opportunity to
study the natural history of coronary calcium. In a period of 5 years,
the measured calcium spots doubled their size.Baseline 5 years Mean diff PMedian calcium
areas
(IQR), mm20.44 (0.28-0.72) 0.75 (0.61-0.90) 0.380.50 <0.001*Median Min. Dist.
From Lumen
(IQR), mm0.17 (0.06-0.25) 0.20 (0.06-0.25) 0.000.15 0.631*Median Max.
Dist. From
Lumen
(IQR), mm0.31 (0.22-0.51) 0.34 (0.21-0.47) 0.020.16 0.389*Mean Dist. From
Lumen, mm0.260.15 0.260.14 0.000.15 0.890ǂAngle, degrees 49.18 (28.35-
62.56)45.98 (37.07-
88.27)12.3724.03 0.003*Length, mm 1.16 (0.85-1.60) 1.23 (0.95-1.76) 0.120.52 0.126*CATEGORIES IMAGING: Intravascular
KEYWORDS Atherosclerosis, coronary, Calciﬁcation, OCTTCT-369
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BACKGROUND Patients and plaque’s characteristics have been scru-
tinized to understand how risk factors relate to the hazard of subse-
quent cardiovascular events. However, the clinical and health
outcomes measures assessed by the Seattle Angina Questionnaire
(SAQ) have never been correlated with the characteristics of obstruc-
tive plaque determined by intravascular ultrasound (IVUS). The aim of
the present study is to describe the pre-treatment intravascular ul-
trasound (IVUS grey scale and backscatter tissue data) ﬁndings of
obstructive lesions according to patient demographics and health
outcome measures in the ABSORB II trial (ClinicalTrials.gov, number
NCT0142528).
METHODS An independent corelab (Cardialysis, Rotterdam, The
Netherlands) analyzed IVUS segments ﬂanked by the presence of side
branches beyond 5mm distally and 5mm proximally to the to be
treated regions. Patient demographics, anthropometric measures,
cardiovascular risk factors and baseline SAQ were correlated with
IVUS ﬁndings. A multivariate analysis was run to identify variables
related to plaque burden and the largest necrotic core area in these
obstructive lesions.
RESULTS 464 patients had pre-procedural IVUS grey-scale and 438
patients had IVUS radiofrequency assessment before device implan-
tation. The mean age was 61.510.0 years old, 23.3% were female and
25.0% were diabetics. Clinical characteristics were able to differen-
tiate plaque features by IVUS and VH IVUS. Patients with abdominal
obesity (P<0.01) and increase in body mass had more negative
remodeling (P¼0.01), a ﬁnding that was related to worse angina fre-
quency scores by SAQ (P<0.01). Reduction in HDL-C (P¼0.01), lesion
in RCA (P<0.01), lesion in proximal LAD (P<0.01) and worse angina
stability by SAQ (P¼0.03) were independently correlated with plaque
burden. Smaller lumen area (P<0.01), larger vessel area (P<0.01) and
more physical limitation by SAQ (P¼0.03) were independently corre-
lated with the maximum necrotic core area.
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clinical characteristics still were able to differentiate the manifesta-
tion of coronary artery disease. Negative remodelling was associated
with worse angina frequency by the SAQ. Patient reported physical
limitation and angina stability were, respectively, associated with
necrotic core size and plaque burden.
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BACKGROUND The illumination of the spontaneous vascular healing
pattern following implantation of the everolimus-eluting Absorb
bioresorbable vascular scaffold (BVS) remains sparse. Optical coher-
ence tomography (OCT) allows accurate and detailed in vivo assess-
ment of the arterial recovery following BVS-implantation.
METHODS OCT was performed in 20 stable angina pectoris patients at
post-procedure and at 9-month follow-up. Baseline struts were clas-
siﬁed according to apposition (well apposed: embedded or protruding,
or incompletely apposed (ISA-struts)), and 9-month struts were clas-
siﬁed according to apposition and coverage. Also, the optical visibility
of the surrounding polymer of the box-shaped struts was assessed at
9-month.
RESULTS One BVS was insufﬁciently ﬂushed post-procedurally, and
excluded from the baseline OCT-assessment. At baseline, 3,745 struts
were analyzed, which of 3,468 struts (92.6%) were apposed (22.4%
were embedded, and the remaining 77.6% were protruding). In total,
277 struts (7.4%) were ISA-struts. At 9-month, 3,883 struts were
analyzed: 12 (0.3%) were ISA, and 76 (2.0%) were located over SBs. All
box-shaped struts were preserved at 9-month, and 2,451 (63.1%) had
persistent surrounding optically visible polymer. Sixteen patients(84.2%) had acute ISA post-procedurally, of which 11 patients (68.8%)
had resolved ISA at 9-month follow-up. No cases of late acquired ISA
were observed at 9-month. In total, 212 struts (5.5%) were incom-
pletely covered. Five uncovered struts were overlying SBs (2.4%), and
the remaining 207 uncovered struts (97.6%) were apposed. None of
the late malapposed struts were uncovered. Of the 3,671 covered
struts (94.5%), 962 (26.2%) were protruding, and 2,709 (73.8%) were
embedded. Three patients (15.0%) had completely covered stents at
the 9-month follow-up.
CONCLUSIONS The rate of acute ISA was high following BVS-im-
plantation in stable target lesions, probably due to underlying pla-
que-related factors and changes in vessel caliber. However, resolved
ISA was observed in the majority of cases, and no cases of late
acquired ISA developed during follow-up. A modest rate of uncov-
ered struts was detected at 9-month, and none of these were
malapposed.
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BACKGROUND Acute Kidney Injury (AKI) is an adverse event asso-
ciated with cardiovascular (CV) procedures and may be caused by the
use of contrast media (CM). Hospitals code AKI via International
Classiﬁcation of Diseases 9th Revision (ICD-9) and then use an add-on
ICD-9 code to indicate that the AKI was a contrast-induced acute
kidney injury (CIAKI). The objective of this study was to assess the
relationship between iso-osmolar CM and low-osmolar CM agents
(LOCM), and CIAKI for those patients undergoing inpatient interven-
tional or diagnostic CV procedures with an AKI event.
